Common Stock, Shares, Outstanding of Inhibikase Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Inhibikase Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Inhibikase Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 74,807,911, a 902% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Inhibikase Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 74,807,911 +67,343,841 +902% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 74,516,635 +67,300,490 +933% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 74,341,540 +67,864,696 +1048% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 69,362,439 +63,176,159 +1021% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 7,464,070 +2,103,744 +39% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 7,216,145 +1,925,319 +36% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 6,476,844 -24,579,394 -79% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 6,186,280 +1,961,986 +46% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 5,360,326 -19,866,725 -79% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 5,290,826 -19,936,225 -79% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 31,056,238 +5,829,187 +23% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 4,224,294 -20,930,904 -83% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 25,227,051 +71,853 +0.29% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 25,227,051 +93,706 +0.37% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 25,227,051 +15,167,202 +151% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 25,155,198 +15,104,349 +150% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 25,155,198 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 25,133,345 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 10,059,849 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 10,050,849 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.